Publications by authors named "Raimundo de Andres"

Claim this Profile
L
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
Leopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, Ovidio Muñiz-Grijalvo, Rodrigo Alonso

Lancet Diabetes Endocrinol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study.
Rodrigo Alonso, Raquel Arroyo-Olivares, Jose Luis Díaz-Díaz, Francisco Fuentes-Jiménez, Francisco Arrieta

Atherosclerosis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study.
Leopoldo Pérez de Isla, Jose L Díaz-Díaz, Manuel J Romero, Ovidio Muñiz-Grijalvo, Juan D Mediavilla

Circ Cardiovasc Imaging· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study.
Rodrigo Alonso, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, Jose Luis Díaz-Díaz, Juan Sanchez Muñoz-Torrero

Eur J Prev Cardiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.
Rodrigo Alonso, Ovidio Muñiz-Grijalvo, Jose Luis Díaz-Díaz, Daniel Zambón, Raimundo de Andrés

J Clin Lipidol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
Leopoldo Pérez de Isla, Gerald F Watts, Rodrigo Alonso, José Luis Díaz-Díaz, Ovidio Muñiz-Grijalvo

Eur Heart J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.
Leopoldo Pérez de Isla, Rodrigo Alonso, José Juan Gómez de Diego, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz

Atherosclerosis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry.
Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz

Rev Esp Cardiol (Engl Ed)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, José Luis Diaz-Díaz, Daniel Zambón

J Clin Lipidol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.
Leopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Daniel Zambón

J Clin Lipidol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.
Rodrigo Alonso, Jose Luis Díaz-Díaz, Francisco Arrieta, Francisco Fuentes-Jiménez, Raimundo de Andrés

J Clin Lipidol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
Adriana Saltijeral, Leopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz, José Luis Díaz-Díaz

Rev Esp Cardiol (Engl Ed)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Cristina Fernández-Pérez, Ovidio Muñiz

Circulation· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Adriana Saltijeral, Ovidio Muñiz

Arterioscler Thromb Vasc Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Leopoldo Perez de Isla, Rodrigo Alonso, Gerald F Watts, Nelva Mata, Adriana Saltijeral Cerezo

J Am Coll Cardiol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B].
Rodrigo Alonso, Pedro Mata, Moises Alonso Y Gregorio, Raimundo de Andrés

Med Clin (Barc)· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of plasma from patients during an acute coronary syndrome.
Petra J Mateos-Cáceres, Antonio García-Méndez, Antonio López Farré, Carlos Macaya, Antonio Núñez

J Am Coll Cardiol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effect of HMG-CoA reductase inhibition on endothelial dysfunction-inducing protein in hypercholesterolemic rabbits].
Ana M Jiménez, Inmaculada Millás, Jerónimo Farré, Antonio García-Méndez, Petra Jiménez

Rev Esp Cardiol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms.
Lourdes Sánchez de Miguel, Ma Mar Arriero, Jerónimo Farré, Petra Jiménez, Antonio García-Méndez

J Am Coll Cardiol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1 -receptor blocker doxazosin.
Antonio López-Farré, Juan A Rodriguez-Feo, Elena García-Colis, Juan Gomez, Almudena López-Blaya

J Hypertens· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis